Involvement of the endocannabinoid system in motor disorders

Current Medicinal Chemistry - Central Nervous System Agents

Volumn 4, Issue 3, 2004, Pages 175-182

  Fernandez Ruiz J J ^a   Lastres Becker, I ^a   Cabranes, A ^a   De Lago, E ^a   Ramos, J A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Basal ganglia; Cannabinoids; CB1 receptors; Endocannabinoid ligands; Motor disorders; Movement; Therapeutic potential

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; AM 374; ANANDAMIDE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOL; DRONABINOL; ENZYME INHIBITOR; FATTY ACID AMIDASE INHIBITOR; LEVODOPA; LIGAND; N (3 FURYLMETHYL)ARACHIDONAMIDE; N (4 HYDROXY 2 METHYLPHENYL)ARACHIDONAMIDE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; NABILONE; RIMONABANT; UNCLASSIFIED DRUG;

BASAL GANGLION; BINDING AFFINITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUNTINGTON CHOREA; MOTOR DYSFUNCTION; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPHARMACOLOGY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PROTEIN LOCALIZATION; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SIGNAL TRANSDUCTION;

EID: 4043097636     PISSN: 15680150     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568015043356922     Document Type: Review

References (97)

1. Fride, E.; Prost Leukot Essent Fatty Acids, 2002, 66, 221-233.
2. Parolaro, D.; Massi, P.; Rubino, T.; Monti, E. Prost. Leukot. Essent. Fatty Acids, 2002, 66, 319-332.
3. Hillard, C.J. J. Pharmacol. Exp. Ther., 2000, 294, 27-32.
4. Consroe, P. Neurobiol. Dis., 1998, 5, 534-551.
5. Sañudo-Peña, M.C.; Tsou, K.; Walker, J.M. Life Sci., 1999, 65, 703-713.
6. Romero, J.; Lastres-Becker, I.; de Miguel, R.; Berrendero, F.; Ramos, J.A.; Fernández-Ruiz, J.J. Pharmacol. Ther., 2002, 95, 137-152.
7. Fernández-Ruiz, J.J.; Lastres-Becker, I.; Cabranes, A.; González, S.; Ramos, J.A. Prost. Leukot. Essent. Fatty Acids. 2002, 66, 263-273.
8. Sañudo-Peña, M.C.; Romero, J.; Seale, G.E.; Fernández-Ruiz, J.J.; Walker, J.M. Eur. J. Pharmacol., 2000, 391, 269-274.
9. Souilhac, J.; Poncelet, M.; Rinaldi-Carmona, M.; Le-Fur, G.; Soubrie, P. Pharmacol. Biochem. Behav., 1995, 51, 3-7.
10. Di Marzo, V.; Lastres-Becker, I.; Bisogno, T.; De Petrocellis, L.; Milone, A.; Davis, J.B.; Fernández-Ruiz, J.J. Eur. J. Pharmacol., 2001, 420, 123-131.
11. Compton, D.R.; Aceto, M.D.; Lowe, J.; Martin, B.R. J. Pharmacol. Exp. Ther., 1996, 277, 586-594.
12. Herkenham, M.; Lynn, A.B.; Little, M.D.; Melvin, L.S.; Johnson, M.R.; de Costa, D.R.; Rice, K.C. J. Neurosci., 1991, 11, 563-583.
13. Herkenham, M.; Lynn, A.B.; de Costa, B.R.; Richfield, E.K.; Brain Res., 1991, 547, 267-264.
14. Mailleux, P.; Vanderhaeghen, J.J. Neuroscience, 1992, 48, 655-668.
15. Tsou, K.; Brown, S.; Sañudo-Peña, M.C.; Mackie, K.; Walker, J.M. Neuroscience, 1998, 83, 393-411.
16. Bisogno, T.; Berrendero, F.; Ambrosino, G.; Cebeira, M.; Ramos, J.A.; Fernández-Ruiz, J.J.; Di Marzo, V. Biochem. Biophys. Res. Comm., 1999, 256, 377-380.
17. Schlicker, E.; Kathmann, M. Trends Pharmacol. Sci., 2001, 22, 565-572.
18. Hernández, M.L.; Berrendero, F.; Suarez, I.; Garcia-Gil, L.; Cebeira, M.; Mackie, K.; Ramos, J.A.; Fernández-Ruiz, J. Brain Res., 2000, 857, 56-65.
19. Mezey, E.; Toth, Z.E.; Cortright, D.N.; Arzubi, M.K.; Krause, J.E.; Elde, R.; Guo, A.; Blumberg, P.M.; Szallasi, A. PNAS (USA), 2000, 97, 3655-3660.
20. Di Marzo, V.; De Petrocellis, L.; Fezza, F.; Ligresti, A.; Bisogno, T. Prostag. Leukot. Essent. Fatty Acids, 2002, 66, 377-391.
21. Zimmer, A.; Zimmer, A.M.; Hohmann, A.G.; Herkenham, M.; Bonner, T.I. PNAS (USA), 1999, 96, 5780-5785.
22. Ledent, C.; Valverde, O.; Cossu, G.; Petitet, F.; Aubert, J.F.; Beslot, F.; Bohme, G.A.; Imperato, A.; Pedrazzini, T.; Roques, B.P.; Vassart, G.; Fratta, W.; Parmentier, M. Science, 1999, 283, 401-404.
23. Di Marzo, V.; Hill, M.P.; Bisogno, T.; Crossman, A.R.; Brotchie, J.M. FASEB J., 2000, 14, 1432-1438.
24. Desarnaud, F.; Cadas, H.; Piomelli, D. J. Biol. Chem., 1995, 270, 6030-6035.
25. Tsou, K.; Nogueron, M.I.; Muthian, S.; Sañudo-Peña, M.; Hillard, C.J.; Deutsch, D.G.; Walker, J.M. Neurosci. Lett., 1998, 254, 137-140.
26. González, S.; Romero, J.; de Miguel, R.; Lastres-Becker, I.; Villanúa, M.A.; Makriyannis, A.; Ramos, J.A.; Fernández-Ruiz, J.J. Life Sci., 1999, 65, 327-336.
27. de Lago, E.; Fernández-Ruiz, J.; Ortega-Gutierrez, S.; Viso, A.; López-Rodriguez, M.L.; Ramos, J.A. Eur. J. Pharmacol., 2002, 449, 99-103.
28. Lastres-Becker, I.; de Miguel, R.; De Petrocellis, L.; Makriyannis, A.; Di Marzo, V.; Fernández-Ruiz, J.J. J. Neurochem., 2003, 84, 1097-1109.
29. Zygmunt, P.M.; Chuang, H.; Movahed, P.; Julius, D.; Hogestatt, E.D. Eur. J. Pharmacol., 2000, 396, 39-42.
30. Miller, A.; Walker, J.M. Eur. J. Pharmacol., 1998, 352, 199-205.
31. Miller, A.; Walker, J.M. Eur. J. Pharmacol., 1996, 304, 29-35.
32. Romero, J.; de Miguel, R.; Ramos, J.A.; Fernández-Ruiz, J.J. Life Sci., 1998, 62, 351-363.
33. Maneuf, Y.P.; Nash, J.E.; Croosman, A.R.; Brotchie, J.M. Eur. J. Pharmacol., 1996, 308, 161-164.
34. Chan, P.K.; Chan, S.C.; Yung, W.H. Neuroreport, 1998, 9, 671-675.
35. Szabo, B.; Dorner, L.; Pfreundtner, C.; Norenberg, W.; Starke, K. Neuroscience, 1998, 85, 395-403.
36. Sañudo-Peña, M.C.; Walker, J.M. J. Neurophysiol., 1997, 77, 1635-1638.
37. Szabo, B.; Wallmichrath, I.; Mathonia, P.; Pfreundtner, C. Neuroscience, 2000, 97, 89-97.
38. Gerdeman, G.; Lovinger, D.M. J. Neurophysiol., 2001, 85, 468-471.
39. Miller, A.; Sañudo-Peña, M.C.; Walker, J.M. Brain Res., 1998, 793, 7-11.
40. Romero, J.; de Miguel, R.; García-Palomero, E.; Fernández-Ruiz, J.J.; Ramos, J.A. Brain Res., 1995, 694, 223-232.
41. Navarro, M.; Fernández-Ruiz, J.J.; de Miguel, R.; Hernández, M.L.; Cebeira, M.; Ramos, J.A. Pharmacol. Biochem. Behav., 1993, 45, 291-298.
42. De Lago, E.; de Miguel, R.; Lastres-Becker, I.; Ramos, J.A.; Fernández-Ruiz, J. Brain Res., 2004, 1007, 152-159.
43. Obeso, J.A.; Rodriguez-Oroz, M.C.; Rodriguez, M.; Arbizu, J.; Gimenez-Amaya, J.M. News Physiol. Sci., 2002, 7, 51-55.
44. Beal, M.F. Trends Neurosci., 2000, 23, 298-304.
45. SuttonBrown, M.; Suchowersky, O. Can. J. Neurol. Sci., 2003, 30 Suppl. 1, S45-52.
46. Martin, W.R.; Wieler, M.; Can. J. Neurol. Sci., 2003, 30 Suppl. 1, S27-33.
47. Müller-Vahl, K.R.; Kolbe, H.; Schneider, U.; Emrich, H.M. Forsch Komplementärned, 1998, 6, 23-27.
48. Brotchie, J.M. Curr. Opin. Pharmacol., 2003, 3, 54-61.
49. Lastres-Becker, I.; Hansen, H.H.; Berrendero, F.; de Miguel, R.; Pérez-Rosado, A.; Manzanares, J.; Ramos, J.A.; Fernández-Ruiz, J.J. Synapse, 2002, 44, 23-35.
50. Grundy, R.I.; Rabuffeti, M.; Beltramo, M. Mol. Neurobiol., 2001, 24, 29-52.
51. Mechoulam, R.; Panikashivili, A.; Shohami, E. Trends Mol. Med. 2002, 8, 58-61.
52. Baker, D.; Pryce, G.; Croxford, J.L.; Brown, P.; Pertwee, R.G.; Huffman, J.W.; Layward, L. Nature, 2000, 404, 84-87.
53. Baker, D.; Pryce, G.; Croxford, J.L.; Brown, P.; Pertwee, R.G.; Makriyannis, A.; Khanolkar, A.; Layward, L.; Fezza, F.; Bisogno, T.; Di Marzo, V. FASEB J., 2001, 15, 300-302.
54. Pertwee, R.G. Pharmacol. Ther., 2002, 95, 165-174.
55. Baker, D.; Pryce, G. Expert Opin. Investig. Drugs, 2003, 12, 561-567.
56. Westlake, T.M.; Howlett, A.C.; Bonner, T.I.; Matsuda, L.A.; Herkenham, M. Neuroscience, 1994, 63, 637-652.
57. Milton, N.G.; Neurosci. Lett., 2002, 332, 127-130.
58. Benito, C.; Nuñez, E.; Tolón, R.M.; Carrier, E.J.; Rábano, A.; Hillard, C.J.; Romero, J. J. Neurosci., 2003, 23, 11136-11141.
59. Berardelli, A.; Noth, J.; Thompson, P.D.; Bollen, E.L.; Curra, A.; Deuschl, G.; van Dijk, J.G.; Topper, R.; Schwartz, M.; Roos, R.A. Mov. Disord., 1999, 14, 398-403.
60. Cattaneo, E.; Rigamonti, D.; Goffredo, D.; Zuccato, C.; Squitieri, F.; Sipion, S. Trends Neurosci., 2001, 24, 182-188.
61. Glass, M.; Faull, R.L.M.; Dragunow, M. Neuroscience, 1993, 56, 523-527.
62. Richfield, E.K.; Herkenham, M. Ann. Neurol., 1994, 36, 577-584.
63. Glass, M.; Dragunow, M.; Faull, R.L.M. Neuroscience, 2000, 97, 505-519.
64. Lastres-Becker, I.; Berrendero, F.; Lucas, J.J.; Martin, E.; Yamamoto, A.; Ramos, J.A.; Fernández-Ruiz, J.J. Brain Res., 2002, 929, 236-242.
65. Denovan-Wright, E.M.; Robertson, H.A. Neuroscience, 2000, 98, 705-713.
66. Lastres-Becker, I.; Bizat, N.; Boyer, F.; Hantraye, P.; Fernández-Ruiz, J.; Brouillet, E. Neuroreport, (In press, 2004).
67. Brouillet, E.; Condé, F.; Beal, M.F.; Hantraye, P. Prog. Neurobiol., 1999, 59, 427-468.
68. Lastres-Becker, I.; Fezza, F.; Cebeira, M.; Bisogno, T.; Ramos, J.A.; Milone, A.; Fernández-Ruiz, J.J.; Di Marzo, V. Neuroreport, 2001, 12, 2125-2129.
69. Page, K.J.; Besret, L.; Jain, M.; Monaghan, E.M.; Dunnett, S.B.; Everitt, B.J. Exp. Brain Res., 2000, 130, 142-150.
70. Lastres-Becker, I.; Gómez, M.; de Miguel, R.; Ramos, J.A.; Fernández-Ruiz, J.J. Neurotox. Res., 2002, 4, 601-608.
71. Factor, S.A.; Firedman, J.H. Mov. Disord., 1997, 12, 483-496.
72. Kieburtz, K.; J. Neural. Transm. Suppl., 1999, 55, 97-102.
73. Müller-Vahl, K.R.; Schneider, U.; Emrich, H.M. Mov. Disord., 1999, 14, 1038-1040.
74. Lastres-Becker, I.; Bizat, N.; Boyer, F.; Hantraye, P.; Brouillet, E.; Fernández-Ruiz, J. Neuroreport, 2003, 14, 813-816.
75. Guzmán, M.; Sánchez, C.; Galve-Roperh, I. J. Mol. Med., 2001, 78, 613-625.
76. Blandini, F.; Nappi, G.; Tassorelli, C.; Martignoni, E. Prog. Neurobiol., 2000, 62, 63-88.
77. Carlsson, A. J. Neural. Transm., 2002, 109, 777-787.
78. Vajda, F.J. J. Clin. Neurosci., 2002, 9, 4-8.
79. Tintner, R.; Jankovic, J. Curr. Opin. Neurol., 2002, 15, 467-476.
80. Lastres-Becker, I.; Cebeira, M.; de Ceballos, M.; Zeng, B.-Y.; Jenner, P.; Ramos, J.A.; Fernández-Ruiz, J.J. Eur. J. Neurosci., 2001, 14, 1827-1832.
81. Romero, J.; Berrendero, F.; Pérez-Rosado, A.; Manzanares, J.; Rojo, A.; Fernández-Ruiz, J.J.; de Yébenes, J.G.; Ramos, J.A. Life Sci., 2000, 66, 485-494.
82. Mailleux, P.; Vanderhaeghen, J.J. J. Neurochem., 1993, 61, 1705-1712.
83. Zeng, B.Y.; Dass, B.; Owen, A.; Rose, S.; Cannizzaro, C.; Tel, B.C.; Jenner, P. Neurosci. Lett., 1999, 276, 71-74.
84. Sañudo-Peña, M.C.; Patrick, S.L.; Khen, S.; Patrick, R.L.; Tsou, K.; Walker, J.M. Neurosci. Lett., 1998, 248, 171-174.
85. Brotchie, J.M. Mov. Disord., 1998, 13, 871-876.
86. Brotchie, J.M. Ann. Neurol., 2000, 47, S105-S114.
87. Sieradzan, K.A.; Fox, S.H.; Hill, M.; Dick, J.P.; Crossman, A.R.; Brotchie, J.M. Neurology, 2001, 57, 2108-2111.
88. Segovia, G.; Mora, F.; Crossman, A.R.; Brotchie, J.M. Mov. Disord., 2003, 18, 138-149.
89. Lastres-Becker, I.; Ramos, J.A.; Mechoulam, R.; Fernández-Ruiz, J. J. Neurosci., (In press, 2004).
90. Meschler, J.P.; Howlett, A.C.; Madras, B.K. Psychopharmacol., 2001, 156, 79-85.
91. Zaretsky, A.; Rector, N.A.; Seeman, M.V.; Fornazzari, X. Schizophrenia Res., 1993, 11, 3-8.
92. Hemming, M.; Yellowlees, P.M. J. Psychopharmacol., 1993, 7, 389-391.
93. Müller-Vahl, K.R.; Kolbe, H.; Schneider, U.; Emrich, H.M. Acta Psychiatr. Scand., 1998, 98, 502-506.
94. Muller-Vahl, K.R.; Schneider, U.; Prevedel, H.; Theloe, K.; Kolbe, H.; Daldrup, T.; Emrich, H.M. J. Clin. Psychiatry, 2003, 64, 459-465.
95. Fox, S.H.; Kellett, M.; Moore, A.P.; Crossman, A.R.; Brotchie, J.M. Mov. Disord., 2002, 17, 145-149.
96. Richter, A.; Löscher, N. Eur. J. Pharmacol., 1994, 264, 371-377.
97. Berrendero, F.; Sánchez, A.; Cabranes, A.; Puerta, C.; Ramos, J.A.; Garcia-Merino, A.; Fernández-Ruiz, J.J. Synapse, 2001, 41, 195-202.